William Rice

Chief Executive Officer at APTOSE BIOSCIENCES INC.

Net worth: 10 131 $ as of 2026-05-30

67 year

69 connections

Health Technology

Consumer Services

Electronic Technology

Profile

William G.
Rice was the founder of Achillion Pharmaceuticals, Inc., founded in 1998, where the titles held included President, Chief Executive Officer & Director from 1998 to 2003.
Current jobs include Chairman, President & Chief Executive Officer at Aptose Biosciences, Inc. since 2013, and Chairman at Cylene Pharmaceuticals, Inc. since 2013, with employment starting in 2003.
Former jobs include Independent Director at Oncolytics Biotech, Inc. from 2015 to 2021, Member-Pediatric Hematology & Oncology at Emory University School of Medicine from 1989 to 1992, and Senior Scientist & Head-Drug Mechanism Lab at Frederick National Laboratory For Cancer Research from 1992 to 1998.
Education includes a doctorate degree from Emory University, conferred in 1986.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
APTOSE BIOSCIENCES INC. 0.24%	2026-02-22	6,140 ( 0.24% )	10 131 $	2026-05-30

William Rice active positions

Companies	Position	Start
APTOSE BIOSCIENCES INC.	Chief Executive Officer	2013-10-27
Cylene Pharmaceuticals, Inc. Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs	Chairman	2010-09-27

All active positions of William Rice

Former positions of William Rice

Companies	Position	End
ONCOLYTICS BIOTECH INC.	Director/Board Member	2020-12-31
ACHILLION PHARMACEUTICALS, INC.	Founder	2003-07-31
Frederick National Laboratory For Cancer Research Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology The Frederick National Laboratory for Cancer Research (FNLCR), operated by Leidos Biomedical Research, Inc. for the National Cancer Institute, is a government-affiliated biomedical research institution dedicated to advancing cancer, AIDS, and infectious disease research. The company is based in Frederick and ultimately controlled by the Government of the United States of America. It offers scientific programs, specialized laboratories, and technological platforms such as cryo-electron microscopy, nanotechnology characterization, molecular diagnostics, protein expression, and laboratory animal sciences. FNLCR develops scientific standards and reference materials to enhance research quality and data reliability, and its initiatives include the RAS Initiative targeting cancer-driving genes, vaccine development programs, precision medicine trials for blood cancers, and viral oncology research. The laboratory supports investigators with scientific expertise, technical services, user facilities, and training modules, and fosters collaboration across government, academia, and industry through technology transfer, licensing, and partnerships. FNLCR also engages in community outreach, workforce development, and diversity initiatives.	Corporate Officer/Principal	1997-12-31
Emory University School of Medicine Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	1991-12-31

See the detail of William Rice's experience

Training of William Rice

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William Rice's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	7
Aptose Biosciences, Inc. Aptose Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers, research and develops anticancer therapies with high safety profiles	Health Technology
Oncolytics Biotech, Inc. Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers	Health Technology
Cylene Pharmaceuticals, Inc. Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small molecule drugs	Health Technology
Achillion Pharmaceuticals, Inc. Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases	Health Technology
Emory University Emory University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Emory University School of Medicine Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Frederick National Laboratory For Cancer Research Frederick National Laboratory For Cancer Research Aerospace & DefenseElectronic Technology The Frederick National Laboratory for Cancer Research (FNLCR), operated by Leidos Biomedical Research, Inc. for the National Cancer Institute, is a government-affiliated biomedical research institution dedicated to advancing cancer, AIDS, and infectious disease research. The company is based in Frederick and ultimately controlled by the Government of the United States of America. It offers scientific programs, specialized laboratories, and technological platforms such as cryo-electron microscopy, nanotechnology characterization, molecular diagnostics, protein expression, and laboratory animal sciences. FNLCR develops scientific standards and reference materials to enhance research quality and data reliability, and its initiatives include the RAS Initiative targeting cancer-driving genes, vaccine development programs, precision medicine trials for blood cancers, and viral oncology research. The laboratory supports investigators with scientific expertise, technical services, user facilities, and training modules, and fosters collaboration across government, academia, and industry through technology transfer, licensing, and partnerships. FNLCR also engages in community outreach, workforce development, and diversity initiatives.	Electronic Technology